Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma

Affiliations

• ¹ Department of Medical Oncology, Cross Cancer Institute, Edmonton, AB, Canada.
• ² Cancer Center, Bendigo Health, Bendigo, Australia.
• ³ University of Alberta, Edmonton, AB, Canada.
• ⁴ The Ottawa Hospital Cancer Center, Ottawa, ON Canada.
• ⁵ Ottawa Hospital Research Institute, Ottawa, ON, Canada.
• ⁶ Cancer Care Manitoba, Winnipeg, MB, Canada.
• ⁷ University of Manitoba, Winnipeg, MB, Canada.
• ⁸ Division of Hematology and Medical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada.
• ⁹ Department of Urological Sciences, University of British Columbia, Vancouver, BC, Canada.
• ¹⁰ Department of Oncology, Queen's University, Kingston, ON, Canada.
• ¹¹ Department of Surgery, McGill University Health Center, Montreal, QC, Canada.
• ¹² Division of Radiation Oncology, University of Ottawa, ON, Canada.
• ¹³ Juravinski Cancer Center, Hamilton, ON, Canada.
• ¹⁴ Division of Medical Oncology/Hematology, Centre Hospitalier de l' Université de Montréal, Montreal, Quebec, Canada.
• ¹⁵ BC Cancer, Vancouver, BC, Canada, University of British Columbia, BC, Canada.
• ¹⁶ Division of Medical Oncology, Western University and London Health Sciences Center, London, ON, Canada.